BP, cardiovascular disease, and death in the folic acid for vascular outcome reduction in transplantation trial

Journal of the American Society of Nephrology

Volumn 25, Issue 7, 2014, Pages 1554-1562

  Carpenter, Myra A ^a   John, Alin ^b   Weir, Matthew R ^c   Smith, Stephen R ^d   Hunsicker, Lawrence ^e   Kasiske, Bertram L ^f   Kusek, John W ^g   Bostom, Andrew ^h   Ivanova, Anastasia ^a   Levey, Andrew S ^b   Solomon, Scott ⁱ   Pesavento, Todd ^j   Weiner, Daniel E ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^h MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AORTA ANEURYSM; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY ARTERY RECANALIZATION; DEATH; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; SECONDARY ANALYSIS; SENSITIVITY ANALYSIS; SMOKING; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HYPERTENSION; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; KIDNEY TRANSPLANTATION; MORTALITY;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 84907200319     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040435     Document Type: Article

References (40)

1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, KasiskeB, KutnerN, Liu J, St PeterW, GuoH, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, SolidC, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. AmJ Kidney Dis 59: A7, e1-e420, 2012
2. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group: Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patientlevel meta-analysis. Ann Intern Med 139: 244-252, 2003
3. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, O'Shaughnessy EA, Dahl DC, Silkensen JR, Sahadevan M, Snyder JJ: Hypertension after kidney transplantation. Am J Kidney Dis 43: 1071-1081, 2004
4. Mange KC, Feldman HI, JoffeMM, Fa K, BloomRD: Blood pressure and the survival of renal allografts fromliving donors. J AmSoc Nephrol 15: 187-193, 2004
5. Opelz G, Döhler B; Collaborative Transplant Study: Improved longterm outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5: 2725-2731, 2005
6. Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 37: 1053-1059, 2001
7. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 363: 918-929, 2010
8. Aronow WS: What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease? ArchMed Sci 8: 399-402, 2012
9. Chang TI, Cheung AK, Chertow GM: Blood pressure control in type 2 diabetes mellitus. Am J Kidney Dis 56: 1029-1031, 2010
10. SarnakMJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS: The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the Modification of Diet in Renal Disease study. Ann Intern Med 142: 342-351, 2005
11. Upadhyay A, Earley A, Haynes SM, Uhlig K: Systematic review: Blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 154: 541-548, 2011
12. Upadhyay A, Uhlig K: Is the lower blood pressure target for patients with chronic kidney disease supported by evidence? CurrOpin Cardiol 27: 370-373, 2012
13. BanachM, AronowWS: Blood pressure j-curve: Current concepts. Curr Hypertens Rep 14: 556-566, 2012
14. Bangalore S, Messerli FH, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC; Treating to New Targets Steering Committee and Investigators: J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J 31: 2897-2908, 2010
15. Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, EsmatjesE, HricikD, PohlM, Raz I, VanhilleP, WiegmannTB, WolfeBM, Locatelli F, Goldhaber SZ, Lewis EJ; Collaborative Study Group: Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 16: 2170-2179, 2005
16. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ: Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144: 884-893, 2006
17. CushmanWC, EvansGW, Byington RP, GoffDCJr, GrimmRHJr, Cutler JA, Simons-MortonDG, Basile JN, CorsonMA, Probstfield JL, Katz L, Peterson KA, FriedewaldWT, Buse JB, Bigger JT, GersteinHC, Ismail-Beigi F, Ismail- Beigi F;ACCORDStudy Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl JMed 362: 1575-1585, 2010
18. Agarwal R: Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol 4: 830-837, 2009
19. PohlMA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ: Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the Irbesartan DiabeticNephropathyTrial:Clinical implications and limitations.JAmSoc Nephrol 16: 3027-3037, 2005
20. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54: 561-569, 1998
21. Kidney Disease ImprovingGlobal Outcomes (KDIGO)Blood PressureWork Group: KDIGO clinical practice guidelines for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2: 337-414, 2012
22. Kidney Disease Improving Global Outcomes (KDIGO) Transplant Work Group: KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9[Suppl 3]: S1-S155, 2009
23. Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, Selhub J, Jacques PF, Cole E, Gravens-Mueller L, House AA, Kew C, McKenney JL, Pacheco-Silva A, Pesavento T, Pirsch J, Smith S, Solomon S, Weir M: Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation 123: 1763-1770, 2011
24. BostomAG, CarpenterMA, Kusek JW, Hunsicker LG, PfefferMA, Levey AS, Jacques PF, McKenney J: Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. Am Heart J 152: 448.e1-448.e7, 2006
25. Bostom AG, Carpenter MA, Hunsicker L, Jacques PF, Kusek JW, Levey AS, McKenney JL, Mercier RY, Pfeffer MA, Selhub J; FAVORIT Study Investigators: Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis 53: 121-128, 2009
26. Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen- Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR; ALERT Study Investigators: Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT Study. Am J Transplant 4: 988-995, 2004
27. Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group: Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 138: 542-549, 2003
28. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, KannelWB, Levy D: Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103: 1245-1249, 2001
29. Haider AW, Larson MG, Franklin SS, Levy D; Framingham Heart Study: Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 138: 10-16, 2003
30. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K: Blood pressure and mortality in U.S. veterans with chronic kidney disease: A cohort study. Ann Intern Med 159: 233-242, 2013
31. Chapman JR: Clinical renal transplantation: Where are we now, what are our key challenges? Transplant Proc 42[Suppl]: S3-S6, 2010
32. Cosio FG, Alamir A, Yim S, Pesavento TE, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 53: 767-772, 1998
33. Lentine KL, Schnitzler MA, Abbott KC, Li L, Burroughs TE, Irish W, Brennan DC: De novo congestive heart failure after kidney transplantation: A common conditionwith poor prognostic implications.Am J Kidney Dis 46: 720-733, 2005
34. Oliveras A, Roquer J, Puig JM, Rodríguez A, Mir M, OrfilaMA, Masramon J, Lloveras J: Stroke in renal transplant recipients: Epidemiology, predictive risk factors and outcome. Clin Transplant 17: 1-8, 2003
35. Carpenter MA, Weir MR, Adey DB, House AA, Bostom AG, Kusek JW: Inadequacy of cardiovascular risk factor management in chronic kidney transplantation-evidence from the FAVORIT study. Clin Transplant 26: E438-E446, 2012
36. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
37. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration):A newequation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
38. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS: Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 56: 486-495, 2010
39. Weiner DE, Carpenter MA, Levey AS, Ivanova A, Cole EH, Hunsicker L, Kasiske BL, Kim SJ, Kusek JW, Bostom AG: Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: The FAVORIT trial. Am J Transplant 12: 2437-2445, 2012
40. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80: 17-28, 2010